Miscellaneous Health Regulations Amendments

Summary#

These are final, technical amendments called Regulations Amending Certain Department of Health Regulations (Miscellaneous Program): SOR/2021-46. They fix wording, bilingual differences and cross‑references across several Health Canada regulations. The changes took effect on March 31, 2021.

What it does#

• Fixes English/French wording differences so both language versions mean the same thing (for example, replacing “shellfish” with mollusc in one place, and aligning terms like “risk” instead of “injury”).
• Clarifies labelling and ingredient text rules (including small formatting options for the French/English word “Ingrédients” and where ingredient lists must appear).
• Corrects inaccurate cross-references to renamed lists (replaces references to Schedule A with Schedule A.1 where needed).
• Updates small wording issues for clarity or consistency (examples: “clinic” → clinical, “therefor” removed from a heading, ISO citation format adjusted to ISO 1750:1981).
• Restores or clarifies specific provisions that were accidentally changed or repealed earlier (for example, some French text in the clinical trial packaging rules and sample-retention wording for distributors).
• Removes a broken web link from the Precursor Control Regulations.
• Tweaks who can suspend a licence or how suspension can be done in certain cases (language changed to focus on preventing risk to health).
• Corrects a reference about who sends a suspension notice (changes “an inspector” to the Minister in one place).
• These amendments apply across a number of instruments administered by Health Canada, including the Food and Drug Regulations, Natural Health Products Regulations, Radiation Emitting Devices Regulations, Medical Devices Regulations, Precursor Control Regulations, and Pest Control Products Regulations.

Who's affected#

• Companies that make, label or sell food, drugs, natural health products and pest control products.
• Medical device manufacturers and holders of establishment licences.
• Sponsors and operators of clinical trials and research importers.
• Importers, distributors and retailers who must follow labelling or sample‑retention rules.
• People and businesses that deal with precursor chemicals.
• Regulators and inspectors at Health Canada who enforce these regulations.
• If it is unclear whether a particular business or product is affected, the source does not spell that out in detail.

Why it matters#

• These are mostly technical and non‑policy fixes. They reduce confusion from inconsistent bilingual wording, bad cross‑references or typos.
• Clearer text and corrected references make it easier for companies to meet regulatory requirements and for inspectors to enforce them consistently.
• The changes were intended to avoid accidental compliance problems and do not create new costs or new regulatory burdens (Health Canada says there is no expected impact on small businesses).
• Because they are minor wording and formatting corrections, they do not change the underlying rules or introduce new policy.